Wellgistics Health, Inc. (WGRX)
NASDAQ: WGRX · Real-Time Price · USD
0.115
-0.010 (-7.70%)
At close: Apr 28, 2026, 4:00 PM EDT
0.117
+0.002 (1.83%)
After-hours: Apr 28, 2026, 7:39 PM EDT

Company Description

Wellgistics Health, Inc. engages in the wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States.

The company distributes branded and generic pharmaceuticals, as well as over-the-counter healthcare and consumer products.

It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers.

It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty.

The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024.

Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.

Wellgistics Health, Inc.
Wellgistics Health logo
Country United States
Founded 2022
IPO Date Feb 21, 2025
Industry Pharmaceutical Retailers
Sector Healthcare
CEO Prashant Patel

Contact Details

Address:
3000 Bayport Drive, Suite 950
Tampa, Florida 33607
United States
Phone 844 203 6092
Website wellgisticshealth.com

Stock Details

Ticker Symbol WGRX
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
IPO Price $4.50
CIK Code 0002030763
CUSIP Number 949503106
ISIN Number US9495031067
Employer ID 93-3264234
SIC Code 5122

Key Executives

Name Position
Prashant Patel M.Sc., R.Ph. Interim-Chief Executive Officer, President and Director
Srinivas Kalla Chief Technology Officer
Dr. Shafaat Pirani Pharm.D. Chief Clinical Officer
Nikul Panchal BCNP, R.Ph. Chief Pharmacy Officer
Gerald E. Commissiong Chief Business Officer

Latest SEC Filings

Date Type Title
Apr 24, 2026 10-K/A [Amend] Annual report
Apr 24, 2026 PRE 14A Other preliminary proxy statements
Apr 21, 2026 8-K/A [Amend] Current report
Apr 17, 2026 8-K Current Report
Apr 15, 2026 S-3 Registration statement under Securities Act of 1933
Apr 9, 2026 8-K Current Report
Apr 7, 2026 8-K Current Report
Apr 3, 2026 DEF 14C Filing
Mar 25, 2026 PRER14C Filing
Mar 25, 2026 PRE 14C Filing